脑膜瘤手术切除后的生活:一项评估健康相关生活质量的前瞻性横断面研究
该研究在单一大中心对291例I级颅内脑膜瘤术后患者进行QLQ-C30问卷评估,共纳入455份问卷。与常模人群相比,患者在术后12、48、108、120个月报告整体健康相关生活质量(HRQoL)显著降低,且认知、情绪、社会功能及疲劳、睡眠障碍与整体HRQoL强相关。作者认为这些症状是整体HRQoL的可干预决定因素,但需未来靶向干预研究验证。
要点
- 脑膜瘤术后患者在12、48、108、120个月的整体HRQoL较常模人群有临床和统计学显著损害。
- 术后12个月各HRQoL子领域均降低,但仅认知功能达到最小临床意义差值。
- 身体、情绪、认知、社会功能及疲劳、睡眠/失眠与整体HRQoL显著相关。
核心结论
- 脑膜瘤患者术后超过120个月仍报告HRQoL显著受限,尤其在认知、情绪和社会功能方面,并伴有显著疲劳和睡眠障碍。
- 大多数报告的功能损害和症状与整体HRQoL强相关,可视为整体HRQoL的决定因素,若加以治疗可能改善脑膜瘤患者的HRQoL。
- 该假设需要未来靶向干预研究来确定其疗效。
研究设计与样本
- 前瞻性、纵向、横断面队列研究。
- 纳入在单一大三级中心常规随访的I级颅内脑膜瘤术后成人患者291例,共纳入455份QLQ-C30问卷。
- 在随访时机会性发放QLQ-C30问卷,比较每12个月间隔的平均转化QLQ-C30评分与常模参考人群评分,并参考已知的最小临床意义差值(CMD)。
主要发现
- 脑膜瘤患者在术后12、48、108、120个月的整体HRQoL较常模人群有临床和统计学显著损害(P < 0.05)。
- 术后12个月时,脑膜瘤患者各HRQoL评估子领域均报告降低(P < 0.05),但CMD仅见于认知功能。
- 术后第一个12个月间隔内,身体、情绪、认知和社会子领域以及疲劳和睡眠/失眠与整体HRQoL显著相关。
- 总体而言,手术时间与整体HRQoL或QLQ-C30子领域功能或症状部分无显著相关性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Few studies have evaluated the health-related quality of life (HRQoL) of patients with meningiomas. Here, we report the largest prospective, longitudinal cross-sectional cohort study of HRQoL in meningiomas to date, in order to identify possible actionable determinants of global HRQoL. METHODS: Adults who had undergone resection of a grade I intracranial meningioma and were in routine follow-up at a single large tertiary center underwent HRQoL assessment using the QLQ-C30 questionnaire administered opportunistically at follow-up visits. Averaged transformed QLQ-C30 scores at 12-month intervals were compared with scores from a normative reference population, with reference to known minimal clinically meaningful difference (CMD) in scores. To evaluate for possible determinants of changes in global HRQoL, global HRQoL scores were correlated (Spearman's Rho) with subdomain and symptom scores and with interval time from surgical resection. RESULTS: A total of 291 postoperative patients with histologically confirmed and surgically treated grade I meningiomas consented to participation and a total of 455 questionnaires were included for analysis. Patients with meningiomas reported reduced global HRQoL at nearly every 12-month interval with clinically and statistically significant impairments at 12, 48, 108, and 120 months postoperative compared with the normative population (P < 0.05). Meningioma patients at the 12-month interval also reported a reduction of each subdomain of HRQoL assessment (P < 0.05); however, a CMD was only seen in cognitive functioning. Physical, emotional, cognitive, and social subdomains, as well as fatigue and sleep/insomnia, were significantly associated with global HRQoL at the first 12-month interval. Overall, there was no significant correlation between time from surgery and global HRQoL or the subdomain functional or symptom sections of the QLQ-C30. CONCLUSIONS: Meningioma patients report considerable limitations in HRQoL for more than 120 months after surgery, particularly in cognitive, emotional, and social function, as well as suffering significant fatigue and sleep impairment compared with a normative reference population. The majority of these reported functional impairments and symptoms are strongly associated with global HRQoL and thus can be considered determinants of global HRQoL that if treated, have the potential to improve HRQoL for our meningioma patients. This hypothesis requires future study of targeted interventions to determine their efficacy.
引用
- Nassiri F, Price B, Shehab A, et al. Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life. Neuro Oncol. 2019. PMID: 30649488. doi:10.1093/neuonc/noy152
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。